KromaTiD Expands Their Gene Therapy Analytic Assay Suite with the Addition of GLP Genomic Integrity Karyotyping Services

LONGMONT, Colo., May 7, 2024 /PRNewswire/ — KromaTiD, a company focused on the research, development, and commercialization of single-cell genomics tools and services for the Cell and Gene Therapy (C>) Market, is launching GLP Genomic Integrity Karyotyping services at the 2024 American…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks